Gestational weight change in a diverse pregnancy cohort and mortality over 50 years: a prospective observational cohort study
Hinkle SN, Mumford SL, Grantz KL, et al.
Lancet. 2023:S0140-6736(23)01517-9.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group
RECOVERY Collaborative Group
Lancet Diabetes Endocrinol. Pub. Online 18 Oct 2023.
Leggi
The relationship between spiritual intelligence and self-management in patients with diabetes type 1
Rafiei S, Souri S, Nejatifar Z, Amerzadeh M
Diabetes Technol Ther. Pub. online 5 Sep 2023.
Leggi
Knowledge, safety, and impact of alcohol consumption in young adults with type 1 diabetes mellitus: a qualitative study
Sergel-Stringer OT, Al-Sallami HS, Styles SE, et al.
BMC Endocr Disord. 2023;23(1):229.
Leggi
Teplizumab and β-cell function in newly diagnosed type 1 diabetes
Ramos EL, Dayan CM, Chatenoud L, et al.
NEJM. Pub. online 18 Oct 2023.
Leggi
Once-weekly insulin icodec versus once-daily insulin degludec as part of a basal-bolus regimen in individuals with type 1 diabetes (ONWARDS 6): a phase 3a, randomised, open-label, treat-to-target trial
Russell-Jones D, Babazono T, Cailleteau R, et al.
The Lancet. Pub. online 17 Oct 2023.
Leggi
Proportion of participants with type 2 diabetes achieving a metabolic composite endpoint with once‐weekly semaglutide treatment versus comparators: Post hoc pooled analysis from SUSTAIN 1‐5, 7‐10 and SUSTAIN China
Ji L, Ahmann AJ, Ahrén B, et al.
Diabetes Obes Metab. Pub. online 12 Oct 2023.
Leggi
Construction and validation of a nomogram for predicting diabetes remission at 3 months after bariatric surgery in patients with obesity combined with type 2 diabetes mellitus
Yuan K, Wu B, Zeng R, et al.
Diabetes Obes Metab. Pub. online 9 Oct 2023.
Leggi
CamAPS FX hybrid closed-loop with ultra-rapid lispro compared with standard lispro in adults with type 1 diabetes: a double-blind, randomized, crossover study
Nwokolo M, Lakshman R, Hartnell S, et al.
Diabetes Technol Ther. Pub. online 12 Oct 2023.
Leggi
Dapagliflozin and physical and social activity limitations in heart failure with reduced ejection fraction
Butt JH, Docherty KF, Kosiborod MN, et al.
J Am Coll Cardiol HF. 2023, 11 (10) 1411–1423.
Leggi